Auxilium Pharmaceuticals Interest Expense:
3.075M for March 31, 2013Auxilium Pharmaceuticals Historical Interest Expense Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 3.075M |
| Dec. 31, 2012 | 0.039M |
| Sept. 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| Dec. 31, 2011 | 0.039M |
| Sept. 30, 2011 | 0.018M |
| June 30, 2011 | 0.088M |
| March 31, 2011 | 0.091M |
| Dec. 31, 2010 | 0.14M |
| Sept. 30, 2010 | 0.101M |
| June 30, 2010 | 0.091M |
| March 31, 2010 | 0.091M |
| Dec. 31, 2009 | 0.091M |
| Sept. 30, 2009 | 0.20M |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| Dec. 31, 2008 | 0.00 |
| Sept. 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
AUXL Interest Expense Benchmarks
| Companies | |
|---|---|
| Catalyst Pharmaceutical Partners | 0.00 |
| Endo Health Solutions | 44.39M |
| Lannett Company | 0.072M |
AUXL Interest Expense Rankings
| Overall |
51st percentile 3854 of 8002 |
| Sector |
21st percentile 513 of 650 in Healthcare |
| Industry |
19th percentile 52 of 65 in Drug Manufacturers - Specialty & Generic |
AUXL Interest Expense Range, Past 5 Years
| Minimum | 0.00 | Jun 2008 |
| Maximum | 3.075M | Mar 2013 |
| Average | 0.2032M |
